Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 1 3Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Thoracic 1

Conditions

Pancreatic Neoplasms 54Carcinoma, Non-Small-Cell Lung 22Neoplasms 17Neoplasm Metastasis 16Breast Neoplasms 16Triple Negative Breast Neoplasms 10Colorectal Neoplasms 9Stomach Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Ovarian Neoplasms 6Melanoma 5Carcinoma, Pancreatic Ductal 5Adenocarcinoma 5Small Cell Lung Carcinoma 4Esophageal Squamous Cell Carcinoma 4Carcinoma, Hepatocellular 4Rectal Neoplasms 3Peritoneal Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Lymphoma, Non-Hodgkin 3Lung Neoplasms 3Hodgkin Disease 3Fallopian Tube Neoplasms 3Carcinoma, Transitional Cell 3Urinary Bladder Neoplasms 2Solid Tumor 2Sarcoma 2Prostatic Neoplasms 2Pancreatic Ductal Adenocarcinoma 2Nasopharyngeal Carcinoma 2

Interventions

pembrolizumab 23Carboplatin 6Pemetrexed 5Paclitaxel 4Cisplatin 4130-nm albumin-bound paclitaxel 3spartalizumab 2Oxaliplatin 2Leucovorin 2Irinotecan 2Fluorouracil 2Axitinib 2Albumin-Bound Paclitaxel 2trametinib 1ribociclib 1osimertinib 1lenvatinib 1etoposide phosphate 1durvalumab 1dabrafenib 1cemiplimab 1binimetinib 1Vascular Endothelial Growth Factor A 1Nivolumab 1Gemcitabine 1Etoposide 1Doxorubicin 1Docetaxel 1DS-8273a 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Parkinson Disease 4, Autosomal Dominant Lewy Body × 130-nm albumin-bound paclitaxel × Clear all
NCT05017012 2026-03-27

MK-3475A-C18

Merck Sharp & Dohme LLC

Phase 1 Active not recruiting
72 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body

NCT03396445 2025-11-05

MK-5890-001

Merck Sharp & Dohme LLC

Phase 1 Completed
182 enrolled 36 charts
BreastThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Neoplasms

NCT02622074 2020-09-10

KEYNOTE 173

Merck Sharp & Dohme LLC

Phase 1 Completed
60 enrolled 26 charts
Breast

Parkinson Disease 4, Autosomal Dominant Lewy Body, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡